Anybody know what this means financially for AFFX? No terms mentioned here, wonder if there has been mention of them in PRs about similar deals in the past.
>SANTA CLARA, Calif. and OSS, Netherlands, June 13 /PRNewswire-FirstCall/ -- Affymetrix, Inc. (Nasdaq: AFFX - News) and Organon announced today that they have entered into a multi-year EasyAccess(TM) Silver agreement under which Organon, an international pharmaceutical company, will gain broad access to Affymetrix' standard and custom GeneChip® arrays, instrumentation and software for use in its pharmaceutical research and development activities.
"We are extremely pleased that Organon chose our GeneChip platform for pharmaceutical research and development and to expand their relationship with Affymetrix going forward," said Mitch Kennedy, general manager, Affymetrix European Business Unit. "Organon's decision demonstrates the growing demand for and standardization on GeneChip technology as customers in Europe continue to recognize the benefits of GeneChip technology for conducting whole-genome and directed analysis."
"Organon has established a strong and productive portfolio of strategic research alliances. The current agreement with Affymetrix strengthens this portfolio and adds important tools for the discovery of differentially expressed genes. This will further improve our ability to identify and validate novel drug targets in our research programs," stated Driek Vergouwen, Managing Director R&D at Organon.<<
snip
Cheers, Tuck |
